Clinical significance of bcl2 and p53 protein expression in diffuse large B-cell lymphoma: A population-based study

Journal of Clinical Oncology

Volumn 14, Issue 7, 1996, Pages 2131-2138

  Kramer, M H ^a   Hermans, J ^a   Parker, J ^a   Krol, A D ^a   Kluin Nelemans, J C ^a   Haak, H L ^a   van Groningen, K ^a   van Krieken, J H ^a   de Jong, D ^a   Kluin, P M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2; PROTEIN P53;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; STATISTICAL ANALYSIS;

EID: 8944262192     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.7.2131     Document Type: Article

References (21)

1. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 329:987-994, 1993
2. Raghoebier S, Kramer MHH, van Krieken JHJM, et al: Essential differences between primary nodal and extranodal large cell lymphomas. Blood 78:2680-2685, 1991
3. Offit K, Wong G, Filippa DA, et al: Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: Clinical correlations. Blood 77:1508-1515, 1991
4. Pezzella F, Tse AGD, Cordell JL, et al: Expression of bcl2 oncogene protein is not specific for the 14:18 chromosomal translocation. Am J Pathol 137:225-232, 1990
5. Rodriquez NR, Rowan A, Smith MEF, et al: P53 mutations in colorectal cancer. Proc Natl Acad Sci USA 87:7555-7559, 1990
6. Piris MA, Pezella F, Martinez-Montero JC, et al: P53 and bcl2 expression in high-grade B-cell lymphomas: Correlation with survival time. Br J Cancer 69:337-341, 1994
7. Villuendas R, Piris MA, Orradre JL, et al: P53 protein expression in lymphomas and reactive lymphoid tissues. J Pathol 166:235-241, 1992
8. Pezella F, Morrison H, Jones M, et al: Immunohistochemical detection of p53 and bcl2 protein in non-Hodgkin's lymphoma. Histopathology 22:39-44, 1993
9. Said JW, Barrera R, Shintaku IP, et al: Immunohistochemical analysis of p53 expression in malignant lymphomas. Am J Pathol 141:1343-1348, 1992
10. Villuendas R, Piris MA, Algara P, et al: The expression of p53 protein is not always dependent on p53 gene mutations. Blood 82:3151-3156, 1993
11. Kocialkowsky S, Pezella F, Morrison H, et al: Mutations in the p53 gene are not limited to classic 'hot spots' and are not predictive of p53 protein expression in high-grade non-Hodgkin's lymphoma. Br J Haematol 89:55-60, 1995
12. Sander CA, Yano T, Clark HM, et al: P53 mutation is associated with progression in follicular lymphoma. Blood 82:1994-2004, 1993
13. Ichikawa A, Hotta T, Tagaki N, et al: Mutations of p53 gene and their relation to disease progression in B-cell lymphoma. Blood 79:2701-2707, 1991
14. Gaidano G, Ballerini P, Gong JZ, et al: P53 mutations in human lymphoid malignancies: Association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc Natl Acad Sci USA 88:5413-5417, 1991
15. Le Coco F, Gaidano G, Louie DC, et al: P53 mutations are associated with histologic transformation of follicular lymphoma. Blood 82:2289-2295, 1993
16. Otter R, Gerrits WBJ, Sandt MM vd, et al: Primary extranodal and nodal non-Hodgkin's lymphoma, a survey of a population-based registry. Eur J Clin Oncol 25:1203-1210, 1989
17. Harris NL, Jaffe ES, Stein H, et al: Perspective: A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 84:1361-1392, 1994
18. Hui PK, Feller AC, Lennert K: High-grade non-Hodgkin's lymphoma of B-cell type: I. Histopathology. Histopathology 12:127-143, 1988
19. Vojtesek B, Bartek J, Midgley CA, et al: An immunochemical analysis of the human nuclear phosphoprotein p53: New monoclonal antibodies and epitope mapping using recombinant p53. J Immunol Methods 151:237-244, 1992
20. Tang SC, Visser L, Hepperle B, et al: Clinical significance of bcl2 mbr rearrangements and protein expression in diffuse large cell lymphoma: An analysis of 83 cases. J Clin Oncol 12:149-154, 1994
21. Hermine O, Haioun C, Lepage E, et al: Prognostic significance of bcl2 protein expression in aggressive non-Hodgkin's lymphoma. Blood 87:265-272, 1996